Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

50.39
Real-Time Quote
 +0.78 / +1.57%
Today’s Change
36.26
Today|||52-Week Range
54.70
+25.72%
Year-to-Date
Wednesdaybs Top Health Care Stories: Zogenix, Endo, and Teva
9:23am / MotleyFool.com
Billionaire George Soros Believes Penn Virginia Corporation (PVA) is Undervalued; Buy...
Apr 09 / Investing Channel
Regulatory Update from Impax - Analyst Blog
Apr 15 / Zacks.com
Notable Analyst Rating Changes 03/14: (TEVA) (SIRI) (LOW) Upgraded; (PLUG) (XOXO) (NU...
Apr 09 / Investing Channel
Down 17%: Is Isis Pharmaceuticals Worth Buying Now?
Apr 15 / MotleyFool.com
Teva to Launch Generic Lovaza - Analyst Blog
Apr 09 / Zacks.com
Teva Unveils Generic Lunesta Tablets in US
Apr 15 / Benzinga
More Trouble Looming for Amarin Corporation?
Apr 09 / MotleyFool.com
TEVA Is a Trade Opportunity
Apr 15 / TheStreet.com
Can Perrigo Company PLC Continue Its Bull Run?
Apr 09 / MotleyFool.com
Tuesdaybs Top Health Care Stories: Johnson & Johnson, Teva, Mylan, and Dynavax
Apr 15 / MotleyFool.com
Pfizer Blockbuster Zyvox Under Attack
Apr 08 / MotleyFool.com
The Supreme Court Will Decide the Fate of a Blockbuster
Apr 14 / MotleyFool.com
This Dividend Portfolio Continues to Dominate
Apr 07 / MotleyFool.com
Is Teva Pharmaceutical Industries Ltd. Destined for Greatness?
Apr 14 / MotleyFool.com
Eli Lilly Signs Deal with Prasco - Analyst Blog
Apr 02 / Zacks.com
This Is the Toughest Part of Investing
Apr 14 / MotleyFool.com
The Medicines Co. Falls on Angiomax Woes - Analyst Blog
Apr 02 / Zacks.com
Three Country ETFs Hitting 52 Week Highs
Apr 10 / Investing Channel
Can ANI Pharmaceuticals, Inc. Beat the Biotech Bubble?
Apr 02 / MotleyFool.com
Notable Analyst Rating Changes 03/19: (JNPR) (TEVA) (EPD) Upgraded; (OWW) (HSBC) (IO)...
Apr 09 / Investing Channel
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.